24 Healthcare Stocks Moving In Friday's Pre-Market Session

Gainers

• Fibrocell Science, Inc. FCSC shares moved upwards by 59.6% to $2.92 during Friday's pre-market session. The market value of their outstanding shares is at $98.3 million.
• Digirad, Inc. DRAD shares rose 15.5% to $5.60. The market cap seems to be at $40.1 million.
• Mallinckrodt, Inc. MNK shares rose 12.7% to $3.37. The most recent rating by Stifel, on September 09, is at Hold, with a price target of $8.00.
• Catalyst Pharmaceuticals, Inc. CPRX stock moved upwards by 11.6% to $6.84. The market cap stands at $46.1 million.
• Akari Therapeutics, Inc. AKTX shares moved upwards by 10.2% to $2.15.
• Geron, Inc. GERN shares moved upwards by 4.4% to $1.65. The market cap stands at $391.6 million. The most recent rating by H.C. Wainwright, on September 03, is at Buy, with a price target of $4.00.
• DBV Technologies, Inc. DBVT shares moved upwards by 4.3% to $10.00. The market value of their outstanding shares is at $1.1 billion. The most recent rating by Goldman Sachs, on June 17, is at Buy, with a price target of $14.00.
• SmileDirectClub, Inc. SDC stock moved upwards by 4.0% to $17.33.
• Celyad, Inc. CYAD shares increased by 3.9% to $10.39. The market cap seems to be at $422.7 million.
• vTv Therapeutics, Inc. VTVT shares surged 3.8% to $1.66.
• Endo International, Inc. ENDP shares rose 3.3% to $4.09. The market cap stands at $644.6 million. The most recent rating by Morgan Stanley, on July 15, is at Underweight, with a price target of $3.00.
• Lannett, Inc. LCI stock moved upwards by 3.1% to $14.30. The market value of their outstanding shares is at $117.3 million. The most recent rating by SunTrust Robinson Humphrey, on August 29, is at Hold, with a price target of $10.00.
• Viveve Medical, Inc. VIVE shares rose 2.0% to $0.08. According to the most recent rating by Ladenburg Thalmann, on July 24, the current rating is at Neutral.

Losers

• Ritter Pharmaceuticals, Inc. RTTR shares decreased by 73.6% to $0.28 during Friday's pre-market session. The market value of their outstanding shares is at $3.5 million.
• Ardelyx, Inc. ARDX stock fell 8.4% to $5.75. The market cap seems to be at $255.5 million.
• Restoration Robotics, Inc. HAIR shares plummeted 7.6% to $0.61. The market cap seems to be at $22.8 million.
• SINTX Technologies, Inc. SINT stock fell 7.1% to $1.97. The market cap stands at $6.5 million.
• Surgery Partners, Inc. SGRY shares plummeted 4.6% to $8.48. The market cap seems to be at $615.7 million.
• AVEO Pharmaceuticals, Inc. AVEO stock plummeted 3.2% to $0.89. The market cap seems to be at $571.7 million. The most recent rating by H.C. Wainwright, on September 11, is at Buy, with a price target of $1.75.
• Lexicon Pharmaceuticals, Inc. LXRX stock decreased by 2.9% to $2.35. The market value of their outstanding shares is at $1.1 billion. According to the most recent rating by Gabelli & Co., on September 11, the current rating is at Buy.
• Valeritas Holdings, Inc. VLRX stock decreased by 2.8% to $1.76. The market value of their outstanding shares is at $69.7 million.
• DelMar Pharmaceuticals, Inc. DMPI shares decreased by 2.5% to $0.62. The market cap seems to be at $24.6 million. The most recent rating by Maxim Group, on September 06, is at Buy, with a price target of $2.00.
• Dr Reddy's Laboratories, Inc. RDY shares plummeted 2.4% to $38.32. According to the most recent rating by Credit Suisse, on September 04, the current rating is at Outperform.
• Leap Therapeutics, Inc. LPTX stock decreased by 2.3% to $1.69.